CJC-1295 GHRH-analog research profile, including DAC vs no-DAC variants and laboratory documentation.
CJC-1295 is a 30-amino-acid analog of GHRH(1-29) engineered with substitutions that confer enzymatic stability. It exists in two distinct research forms: with DAC (Drug Affinity Complex), which extends half-life via albumin binding, and no-DAC, which retains native pulsatile signaling kinetics.
Research use only. Absorb Labs supplies materials strictly for in vitro and laboratory research. Nothing in this article constitutes medical, therapeutic, or dosage advice for human or animal use.
